What I Read This Week…
President Trump announces 90-day pause on proportional tariffs, companies are developing the infrastructure for multi-agent AI systems, and airborne microplastics enter our food supply through plants
Read our Short Dive: The Trump Administration’s Fiscal Strategy
Caught My Eye…
Last week, President Trump maintained the baseline 10% tariff on all imports and announced a 90-day pause on his country-specific tariff increases, with the exception of China where he punitively raised tariffs to 145% (combining a new 125% proportional tariff on top of the existing 20% baseline). After those actions, the President announced that he was carving out exemptions for semiconductors and certain electronics that were critical to U.S. technology supply chains. China responded to the punitive tariffs with multifaceted retaliation, raising tariffs from 84% to 125% by the end of the week, effectively halting bilateral trade. China also suspended exports of rare earth minerals and specialized magnets to the U.S., leveraging its near-monopoly on these materials to target U.S. vulnerabilities. To counteract these actions, President Trump initiated plans to stockpile rare earth minerals and expand domestic deep-sea rare earth mining operations. Beyond China’s response, the EU, Canada, and Mexico have responded with measured resistance, with the EU proposing 25% counter-tariffs on select U.S. products scheduled for mid-May. Around 75 other countries have sought discussions with the President’s administration, with many capitulating and offering concessions, including decreasing their tariffs on U.S. products and commitments to buy American-made products, including U.S.-made aircraft and agricultural products. The administration has strategic objectives and a game plan, but they want to avoid revealing a roadmap that would give trading partners (namely China) opportunities to develop effective counter-strategies. At this point, it’s unclear how U.S. tariff policy will continue to develop.
Companies are currently developing communication standards as part of the infrastructure for multi-agent AI systems. Today, AI agents are optimized to accomplish narrow, domain-specific tasks because there is a trade-off between the reliability of these agents and the broadness of the tasks given to them to complete. This creates AI silos, making it useful to build systems that connect these isolated agents so they can collectively accomplish complex, multi-step tasks with low failure rates. To bridge these silos, companies are creating standardized protocols that enable agents to work together seamlessly. These protocols define how agents can discover each other's capabilities, exchange information securely, and coordinate their activities while preserving context across interactions. The approach mirrors how HTML established a common language for documents to be shared across the early internet, creating a foundation for more complex interactions. With standardized communication frameworks in place and industry consensus forming around key protocols, organizations can more rapidly build integrated multi-agent systems that operate across teams or between companies. This enables complex workflows like hiring processes where a recruiting agent finds candidates, an HR agent verifies credentials, and a calendar agent schedules interviews, all working together seamlessly. As these standards mature, we may see the emergence of an interconnected "internet of agents" where specialized AI systems are dynamically assembled to solve difficult problems and automate complex workflows.
Recent research has uncovered that airborne microplastics enter our food supply through plant leaves. While previous studies focused primarily on soil and water contamination, scientists have now confirmed that airborne microplastics can be absorbed directly by plants. Originating from synthetic clothing, tire wear, and industrial emissions, these tiny plastic particles travel through air currents before landing on leaves. Plants absorb these particles through small pores on leaf surfaces. Once inside the plant, microplastics can move through the plant's vascular system and accumulate in edible parts like leaves, fruits, and grains. This pathway has implications for both human health and ecology. For humans, ingesting microplastics through food may cause inflammation and disrupt gut microbiomes. These particles can also carry toxic chemicals that may be released in the body. In plants, microplastics can interfere with normal processes, including photosynthesis and water regulation. Studies also indicate that exposure to nanoplastics can reduce chlorophyll content and slow plant growth. The concentration of microplastics varies by location, with urban gardens near high-traffic areas showing higher levels than rural sites, and plants with textured leaves capturing more airborne particles than those with smooth surfaces.
Other Reading…
The Chinese Goods Affected by Trump’s Tariffs (Financial Times)
House GOP Budget Framework Paves Way for ‘Big, Beautiful Bill’ (Politico)
Apple Vision Pro 2 Cheaper, Mac-Tethered Headset Coming Too (UploadVR)
Apple India Produces $22 Billion of iPhones in Shift From China (Bloomberg)
Amazon Enters AI Voice Race With Voice Model that Detects Emotion (GeekWire)
ChatGPT Hits 1 Billion Users? ‘Doubled In Just Weeks’ (Forbes)
Quark Surpasses DeepSeek as China’s Top AI App (South China Morning Post)
Netflix Tests New AI Search Engine to Recommend Shows (Bloomberg)
Everything Wrong with Model Context Protocol (Shrivu Shankar)
Compute in America: A Policy Playbook (Institute for Progress)
On X…
I love reading these at the start of the week. They keep me informed before club meetings and as the week unfolds. Thank you, Chamath, for posting this!
Good afternoon,
My name is Travis Jackson, I am a practicing physician in Florida. I am writing this message in hopes that it reaches Mr. Chamath Palihapitiya.
I watched your interview with Tucker Carlson a couple of months back and listened to how involved you are with AI in the surgical/medical setting in terms of better outcomes for breast cancer surgeries and reducing medical errors. It was intriguing and brilliant.
Please allow me to give some background on my context here.
I have been in the medical field for over 20 years now. I started my career in surgery as a premed student. During those 10 years I witnessed a lot of IV drug waste and abuse by healthcare professionals. I have spent the last 15 years developing a module that eliminates open access of IV narcotics to prevent drug abuse in hospitals and reducing the cost of these drugs to the patient by only charging to the patient what was actually administered.
Currently, each vial or unit of drug is charged to the patient regardless of how much was administered or wasted. At the end of the surgical procedure or even on the floor what wasn’t dispensed to the patient is “wasted”, which requires a witness, and the entire unit is charged. I witnessed firsthand healthcare professionals who had a drug problem fraudulently signing off on the amount that was wasted into the sharps bin and taking this waste home for recreational use. Some of whom I found out were caught and had to answer to the board of medicine. This is tragic to allow such a fleeting temptation to have such an impact on all of one’s hard work and dedication to earn their medical degree and right to practice. It also drives up the cost of said drugs with so much waste. Regardless if 1cc or the entire unit was administered, the entire unit is charged to the patient.
This is why I have patented a fully secure and automated IV drug dispensing module, MediLock, that houses and dispenses all IV narcotics directly into the IV line. It eliminates open access and only charges to the patient that which was actually administered into the IV line. It also removes the need for syringes and needles which significantly reduces contaminated needle exposure to the healthcare professional.
There is so much more I would like to discuss as far as how it works but it is difficult through text.
I do have a design PDF and a pitch deck I believe would interest you. I am looking to bring this to the market to completely change how IV drugs are administered and charged.
Mr. Palihapitiya, if this interests you please reach out to me and I will send you the design and pitch deck, my contact info is below.
Sales@MediLock.org